CANCER TYPE Breast cancer
INSTITUTION Olivia-Newton John Cancer Research Institute
GRANT TYPE $100,000
PROJECT TYPE Support
"This observational study will create a national registry for patients with very limited metastatic breast cancer (called “oligometastatic disease”). It aims to identify patients who may be cured with multimodality therapy. Ultimately this study can help to establish national guidelines on how to best treat this special population of patients.
Dr Belinda Yeo, researcher at Olivia Newton-John Research Institute